Medicare Enrolled
Dr. Amir Shokrae, M.D.
Optician · Orange, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Shokrae from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shokrae?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Shokrae
Dr. Amir Shokrae is an optician specialist in Orange, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Shokrae performed 17,618 Medicare services across 1,460 unique beneficiaries.
Between the years covered by Open Payments, Dr. Shokrae received a total of $33,376 from 93 pharmaceutical and/or device companies across 1598 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Shokrae is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 6% volume in CA
$33,376 industry payments
Medicare Practice Summary
Medicare Utilization ↗17,618
Medicare services
Top 6% in CA for optician
1,460
Unique beneficiaries
$17
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~927 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
14,726 | $5 | $7 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,223 | $99 | $150 |
| Continuous intraoperative neurophysiology monitoring, remote Remote monitoring of nerve and brain function during surgery, billed in 15-minute increments. |
671 | $27 | $75 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
122 | $86 | $200 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
119 | $88 | $300 |
| Bilateral facial and neck nerve muscle paralysis injection Injection of a chemical agent to paralyze muscles in the face and neck on both sides. |
112 | $127 | $750 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
101 | $100 | $153 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
83 | $32 | $100 |
| Placement of skin electrodes and measurement of stimulated sites on arms and legs This procedure involves placing skin electrodes and measuring stimulated sites on the arms and legs. |
77 | $37 | $399 |
| Electromyography of 2 extremities A test that measures the electrical activity in the muscles of two arms or legs. It helps evaluate nerve and muscle function. |
65 | $68 | $400 |
| Nerve conduction studies, 13 or more A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed. |
56 | $247 | $850 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
44 | $145 | $350 |
| Central motor stimulation test of arms and legs This procedure involves placing skin electrodes on the body to measure how the central nervous system stimulates the muscles in the arms and legs. |
34 | $99 | $400 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
30 | $46 | $85 |
| EEG brain wave monitoring, 41-60 minutes This procedure involves monitoring and recording electrical activity in the brain using electrodes placed on the scalp for a duration of 41 to 60 minutes. |
20 | $273 | $650 |
| VEMP testing of lower inner ear nerve branch A diagnostic test that evaluates the function of the lower branch of the inner ear nerve. The procedure includes interpretation of the results and a written report. |
18 | $68 | $153 |
| Balance testing with recording A procedure to evaluate balance function by recording the results during testing. |
18 | $96 | $185 |
| Use of electrodes during balance testing Application of electrodes to monitor physiological responses during a balance assessment. |
18 | $10 | $35 |
| Test to assess electrical potentials generated in the inner ear as a result of sound stimulation | 18 | $102 | $195 |
| Auditory brainstem response test A test that measures how the brain responds to sound to help diagnose nervous system disorders. The results are interpreted and reported by a medical professional. |
18 | $75 | $160 |
| Vestibular function test using rotating chair This test evaluates eye movement and balance function by having the patient sit in a rotating chair. It helps assess how the inner ear and brain coordinate to maintain stability. |
16 | $118 | $190 |
| Virtual check-in for established patient A brief communication service provided by a qualified healthcare professional to an established patient via technology, such as a virtual check-in. |
16 | $11 | $45 |
| Vestibular function test with thermal irrigation A test that assesses balance by irrigating both ears with warm and cool fluids to evaluate inner ear function. |
13 | $35 | $80 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$33,376
Total received (2018-2024)
Avg $4,768/year across 7 years
Top 7% in CA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
93
Companies
1,598
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$33,070 (99.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$306 (0.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$6,959
2023
$5,472
2022
$5,011
2021
$3,693
2020
$3,132
2019
$4,455
2018
$4,654
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
UCB, Inc.
$824
ABBVIE INC.
$709
Neurocrine Biosciences, Inc.
$439
Eisai Inc.
$399
Novartis Pharmaceuticals Corporation
$383
SK Life Science, Inc.
$383
Biogen, Inc.
$343
Alexion Pharmaceuticals, Inc.
$276
TG Therapeutics, Inc.
$251
PFIZER INC.
$233
Lilly USA, LLC
$231
ARGENX US, INC.
$226
Lundbeck LLC
$216
Amneal Pharmaceuticals LLC
$214
CSL Behring
$176
Vanda Pharmaceuticals Inc.
$167
EMD Serono, Inc.
$142
Grifols USA, LLC
$133
MDD US Operations, LLC
$120
Celgene Corporation
$108
Neurelis, Inc.
$107
Kyowa Kirin, Inc.
$105
Ipsen Biopharmaceuticals, Inc
$88
LivaNova USA, Inc.
$85
Otsuka America Pharmaceutical, Inc.
$75
BANNER LIFE SCIENCES, LLC
$75
HARMONY BIOSCIENCES LLC
$72
MITSUBISHI TANABE PHARMA AMERICA, INC.
$65
ACADIA Pharmaceuticals Inc
$51
Genentech USA, Inc.
$46
SCILEX PHARMACEUTICALS INC.
$38
NEUROPACE, INC.
$38
Abbott Laboratories
$37
JAZZ PHARMACEUTICALS INC.
$28
AstraZeneca Pharmaceuticals LP
$24
CATALYST PHARMACEUTICALS, INC.
$21
Takeda Pharmaceuticals U.S.A., Inc.
$17
Octapharma USA, Inc.
$14
Top 3 companies account for 28.3% of 2024 payments
All-time payments by company (2018-2024) ›
Biogen, Inc.
$2,821
UCB, Inc.
$2,097
Novartis Pharmaceuticals Corporation
$1,619
Alexion Pharmaceuticals, Inc.
$1,604
Lundbeck LLC
$1,504
SK Life Science, Inc.
$1,314
AbbVie Inc.
$1,234
ABBVIE INC.
$1,159
EMD Serono, Inc.
$1,131
Amgen Inc.
$1,015
Neurocrine Biosciences, Inc.
$908
Supernus Pharmaceuticals, Inc.
$887
Teva Pharmaceuticals USA, Inc.
$762
Lilly USA, LLC
$753
Eisai Inc.
$741
Genentech USA, Inc.
$709
Amneal Pharmaceuticals LLC
$694
Jazz Pharmaceuticals Inc.
$693
PFIZER INC.
$625
GENZYME CORPORATION
$624
CSL Behring
$572
ARGENX US, INC.
$531
ACADIA Pharmaceuticals Inc
$508
Allergan Inc.
$495
Ipsen Biopharmaceuticals, Inc
$447
Grifols USA, LLC
$376
Avanir Pharmaceuticals, Inc.
$370
Adamas Pharmaceuticals, Inc.
$368
Celgene Corporation
$361
MDD US Operations, LLC
$290
Allergan, Inc.
$289
NOVARTIS PHARMACEUTICALS CORPORATION
$272
Harmony Biosciences LLC
$258
TG Therapeutics, Inc.
$251
EISAI INC.
$247
Biohaven Pharmaceutical Holding Company Ltd.
$246
Janssen Pharmaceuticals, Inc
$237
Biohaven Pharmaceuticals, Inc.
$230
Sunovion Pharmaceuticals Inc.
$222
Greenwich Biosciences, Inc.
$193
Kyowa Kirin, Inc.
$185
BANNER LIFE SCIENCES, LLC
$173
Acorda Therapeutics, Inc
$170
Vanda Pharmaceuticals Inc.
$167
Forte Bio-Pharma LLC
$167
Otsuka America Pharmaceutical, Inc.
$162
Takeda Pharmaceuticals U.S.A., Inc.
$162
Neurelis, Inc.
$158
HARMONY BIOSCIENCES LLC
$153
TG THERAPEUTICS, INC.
$153
Banner Life Sciences, LLC
$151
GE Healthcare
$125
Abbott Laboratories
$111
LivaNova USA, Inc.
$98
CATALYST PHARMACEUTICALS, INC.
$93
UPSHER-SMITH LABORATORIES LLC
$82
MITSUBISHI TANABE PHARMA AMERICA, INC.
$80
Impax Laboratories, Inc.
$77
Vertical Pharmaceuticals, LLC
$76
AstraZeneca Pharmaceuticals LP
$75
US WorldMeds, LLC
$72
Merz Pharmaceuticals, LLC
$66
E.R. Squibb & Sons, L.L.C.
$59
Merck Sharp & Dohme LLC
$56
Merz North America, Inc.
$56
Medtronic, Inc.
$55
Mallinckrodt Hospital Products Inc.
$51
JAZZ PHARMACEUTICALS INC.
$48
Catalyst Pharmaceuticals, Inc.
$47
Akcea Therapeutics, Inc.
$44
Upsher-Smith Laboratories LLC
$42
Merck Sharp & Dohme Corporation
$40
Scilex Pharmaceuticals Inc.
$39
SCILEX PHARMACEUTICALS INC.
$38
NEUROPACE, INC.
$38
AbbVie, Inc.
$34
Amylyx Pharmaceuticals, Inc.
$32
Bayer HealthCare Pharmaceuticals Inc.
$29
GE HealthCare
$26
Horizon Therapeutics plc
$22
Corium, LLC
$21
Novo Nordisk Inc
$19
Bausch Health US, LLC
$19
AQUESTIVE THERAPEUTICS, INC.
$19
ASSERTIO THERAPEUTICS, Inc.
$18
MERZ NORTH AMERICA, INC.
$17
Alfasigma USA, Inc.
$15
Arbor Pharmaceuticals, Inc.
$15
ASSERTIO THERAPEUTICS, INC.
$15
Octapharma USA, Inc.
$14
BOSTON SCIENTIFIC CORPORATION
$12
Mitsubishi Tanabe Pharma America, Inc.
$12
Almatica Pharma LLC
$11
Top 3 companies account for 19.6% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADLARITY · ADUHELM · AFINITOR · AGAMREE · AIMOVIG · AJOVY · AMPYRA · AMYVID · APLENZIN · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aduhelm · Aimovig · Austedo XR · BAFIERTAM · BELSOMRA · BOTOX · BOTOX THERAPEUTIC · BRILINTA · BRIUMVI · Betaseron · Briviact · COMIRNATY · COPAXONE · CREXONT · Cambia · DAYBUE · DISEASE STATE · DIVIGEL · DUOPA · DYSPORT · Dayvigo · Duopa · Dysport · EMGALITY · EVUSHELD · Enspryng · Epidiolex · FIRDAPSE · FYCOMPA · Fycompa · GAMMAGARD · GILENYA · GOCOVRI · GRALISE · Gamunex-C · Gocovri · Gralise · HYQVIA · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · KESIMPTA · KISUNLA · LEMTRADA · LINQ II · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MYOBLOC · Mavenclad · NAMZARIC · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nalocet · Nayzilam · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONFI · OSMOLEX ER · OXTELLAR XR · Ocrevus · PANZYGA · PAXLOVID · PIPELINE-MS · PLEGRIDY · PONVORY · Ponvory · QULIPTA · RADICAVA · RELYVRIO · REXULTI · RNS Neurostimulator Kit · RYTARY · Rebif · Rystiggo · SOLIRIS · SPINRAZA · SPRAVATO · SUNOSI · SYMPAZAN · Saxenda · Soliris · TECFIDERA · TEGSEDI · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · UBRELVY · ULTOMIRIS · UNITHROID · UPLIZNA · VALTOCO · VERCISE · VIBERZI · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VRAYLAR · VUMERITY · VYALEV · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAKIX · Wakix · XARELTO · XCOPRI · XEOMIN · XYREM · XYWAV · Xadago · Xeomin · Xyrem · ZEMBRACE SYMTOUCH · ZEPOSIA · ZTLido · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 7% for optician in CA.
Geographic Context
Opticians within 10 mi
1,034
Per 100K population
32.7
County median income
$113,702
Nearest hospital
PROVIDENCE ST. JOSEPH HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Shokrae is a mixed practice specialist, with above-average Medicare volume (top 6% in CA), with low-engagement industry engagement in the top 7% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Shokrae experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Shokrae performed 14,726 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Shokrae receive payments from pharmaceutical companies?
Yes. Dr. Shokrae received a total of $33,376 from 93 companies across 1,598 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shokrae's costs compare to other opticians in Orange?
Dr. Shokrae's average Medicare payment per service is $17. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shokrae) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Orange
Browse opticians in Orange ranked by procedure volume and transparency data.
Highest volume
Top Opticians in CA
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in CA
Which CA opticians receive the most from drug and device companies.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology